Neratinib
3144A2-1115 / B1891001
Phase 1 small_molecule completed
Quick answer
Neratinib for Advanced Malignant Solid Tumors is a Phase 1 program (small_molecule) at PUMA BIOTECHNOLOGY, INC. with 3 ClinicalTrials.gov record(s).
Program details
- Company
- PUMA BIOTECHNOLOGY, INC.
- Indication
- Advanced Malignant Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed